Program Details: 3rd Annual Indiana CTSI Symposium
The Third Annual Indiana Clinical and Translational Sciences Institute (CTSI)
Symposium on Disease and Therapeutic Response Modeling
November 5 and 6, 2013
We are pleased to announce that the third annual Indiana Clinical and
Translational Sciences Institute (CTSI) Symposium on Disease and Therapeutic
Response Modeling will take place on November 5-6, 2013 in Indianapolis,
Indiana. This two-day program will include speakers from academia, industry and
regulatory agencies, as well as poster presentations.
(Program details at the bottom of this email)
REGISTRATION
Link to registration:
Academic, Government and Eli Lilly Company Free Symposium
http://operations.medicine.iu.edu/index.php?cID=163
Industry $200 Paid Symposium
https://indianauniv.ungerboeck.com/prod/SignIn.aspx?ReturnUrl=%2fprod%2femc00%2fregister.aspx%3fOrgCode%3d10%26EvtID%3d5870%26AppCode%3dREG&OrgCode=10&EvtID=5870&DictSeq=27&Lang=*&SessionID=ejofbkfe6ffofb5fc9&CultureInfo=en-US&AppCode=REG
CONFERENCE LOCATION:
Campus Center
420 University Blvd. CE 278
Indianapolis, IN, 46202, Phone: (317) 274-5555
POSTER SESSION: Poster Session / Cocktail Reception will be held on November
5th from 5:30 – 7:00 pm. If you are interested in submitting a poster for
this session, please contact us no later than October 25, 2013.
For more information or questions, please contact Shripad Chitnis
([email protected]<mailto:[email protected]>) or Nieves Velez de Mendizabal
([email protected]<mailto:[email protected]>)
We look forward to seeing you in November!
Program Details:
Tuesday, November 5, 2013
8:00 AM Breakfast / Registration (30 min)
8:30 AM: Welcoming Remarks
Anantha Shekhar, M.D., Ph.D., Associate Dean for Translational Research,
Professor of Pharmacology and Neurobiology, Indiana University School of
Medicine
8:45 AM: Welcoming Remarks
Robert Bies, Ph.D., Director of the Disease Modeling Program for the Clinical
and Translational Sciences Institute (CTSI), Indiana University School of
Medicine
8:50 AM: Keynote Address:
Vikram Sinha, Ph.D., Office of Clinical Pharmacology, Translational Sciences,
FDA
9:30 AM: Eric Meslin, Ph.D., Center for Bioethics at Indiana University School
of Medicine
“Traversing the Science Policy Valley of Death as a Strategy for Accelerating
Translational Science”
10:10 AM Coffee Break (20 min)
10:30 AM: Mark Sale, M.D., Next Level Solutions, LLC
“Open Source NLME in Julia - Opportunity and Request for Wishlists”
11:10 AM: Marc Gastonguay, Ph.D., Metrum Research Group LLC
TBA
11:50 AM: Sorell Schwartz, Ph.D., Center for Biologics Evaluation and Research,
Office of Biostatistics and Epidemiology, FDA
“Is There a Need or Role for Preclinical Safety Assessment of Systemic
Mesenchymal Stem Cell Therapy? Agent Based Modeling Applications”
12:30 PM Lunch (1 hr 15 min)
1:45 PM: Michael Brier, Ph.D., Department of Medicine, Division of Nephrology,
University of Louisville
“Model Predictive Control Applied to Therapeutic Drug Monitoring”
2:25 PM: Jeff Barrett, Ph.D., The Children's Hospital of
http://www.linkedin.com/company/166358?trk=prof-0-ovw-curr_pos
"Design, Governance and Implementation of a Web-Enabled Decision Support Tool
to Manage High-Dose Methotrexate Pharmacotherapy in Children with Cancer"
3:05 PM Coffee Break (30 min)
3:35 PM: Andrew Saykin, Psy.D., Indiana Alzheimer's Disease Center, Center for
Neuroimaging, Indiana University School of Medicine
“Advances in Imaging, Genetics and Biomarkers for Prodromal Alzheimer’s Disease”
4:15 PM: Joaquín Goñi, Ph.D., Department of Psychological & Brain Sciences,
Indiana University
“Network Measures Relating the Human Connectome to Resting-State Functional
Connectivity”
4:55 PM: Klaus Romero, MD., Critical Path Institute
“A Comprehensive Clinical Trial Simulation Tool for Alzheimer’s Disease:
Lessons for Model Collaboration”
5:30 PM: Poster Session and Cocktail Reception
Wednesday, November 6, 2013
7:45 AM Breakfast (30 min)
8:15 AM: Bernard Vrijens, Ph.D., MeadWestvaco Healthcare
“Enrichment strategies for ambulatory clinical trials through
measurement-guided management of patient adherence”
8:55 AM: John Urquhart, M.D., AARDEX Group
“Minimum sampling rate of drug dosing histories to assure accurate, continuous,
pharmacometric projections of internal drug exposure”
9:35 AM: Sean Mooney, Ph.D., Buck Institute for Research on Aging
“Are We There Yet? Progress Toward Clinical Interpretation of the Human Genome”
10:15 AM Coffee Break (20 min)
10:35 AM: Brian Topp, Ph.D., Eli Lilly and Company
“Application of Physiologic-Based Models to the Development of Novel Therapies
for
Type 2 Diabetes”
11:15 AM: Timothy Waterhouse, Ph.D., Eli Lilly and Company
“Evaluating Error Rates in Model-Based Predictions of Drug-Drug Interaction”
11:55 AM Lunch (1 hr 10 min)
1:05 PM: Michael Heathman, Ph.D., Eli Lilly and Company
“Concentration-Response Modeling of Adverse Event Data Using a Markov Chain
Approach”
1:45 PM: Nieves Velez de Mendizabal, Ph.D., CTSI Disease and Therapeutic
Modeling Program
Division of Clinical Pharmacology, Indiana University School of Medicine
"Understanding and Predicting Multiple Sclerosis: A computational Approach"
2:25 PM: Claire Li, Department of Medical and Molecular Genetics, IU
TBA
2:45 PM: Immanuel Freedman, Ph.D., GlaxoSmithKline
Robert Bies, Ph.D., CTSI, Indiana University School of Medicine
"Chaos Synchronization."
Closing remarks: Robert Bies, Ph.D.